Anyone want to take a stab at offering an opinion on what else we need to do in the way of clinical trials etc.(presuming any further trials if needed have the same successes) to motivate a potential partner/buyer ?.. What else needs to happen on our end to force the issue? We have all read about past partnerships/buyouts etc..., involving small biotechs in various stages of development and age....I know there is no definitive answer, but I am hoping that one or more of the knowledgeable posters here might be willing to opine ...